EDITION : English/Korean

Nav
Updated

Tag : HIV virus new treatment

FDA approved Juluca, a new drug combination of dolutegravir and rilpivirine from GSK to fight HIV virus.

Nov 25, 2017 AM EST - Maureen Santos

FDA Approved Juluca, GlaxoSmithKline's New Two-Drug Combination to Treat HIV Virus

A new drug will soon be available in the market to treat HIV virus. Viiv is the manufacturer of the new medicine with the combination of dolutegravir, and rilpivirine and is named Juluca.

Connect with us : facebook twitter google rss

Subscribe to our Newsletter

Real Time Analytics